Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
美罗培南与哌拉西林-他唑巴坦治疗由产 AmpC β-内酰胺酶的肠杆菌属、弗氏柠檬酸杆菌、摩根氏摩根菌、普罗维登斯菌属或粘质沙雷氏菌引起的血流感染的疗效比较:一项多中心随机对照试验(MERINO-2)
期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofab387
Stewart, Adam G; Paterson, David L; Young, Barnaby; Lye, David C; Davis, Joshua S; Schneider, Kellie; Yilmaz, Mesut; Dinleyici, Rumeysa; Runnegar, Naomi; Henderson, Andrew; Archuleta, Sophia; Kalimuddin, Shirin; Forde, Brian M; Chatfield, Mark D; Bauer, Michelle J; Lipman, Jeffrey; Harris-Brown, Tiffany; Harris, Patrick N A